222834-28-8

Basic information

• Product Name: [(2S),N(1S)]-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxy-N-(2-hydroxy-1-phenylethyl)propanamide
• Synonyms: [(2S),N(1S)]-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxy-N-(2-hydroxy-1-phenylethyl)propanamide
• CAS NO: 222834-28-8
• Molecular Weight: 538.643
• Mol File: 222834-28-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: [(2S),N(1S)]-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxy-N-(2-hydroxy-1-phenylethyl)propanamide(CAS DataBase Reference)
• NIST Chemistry Reference: [(2S),N(1S)]-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxy-N-(2-hydroxy-1-phenylethyl)propanamide(222834-28-8)
• EPA Substance Registry System: [(2S),N(1S)]-3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxy-N-(2-hydroxy-1-phenylethyl)propanamide(222834-28-8)

Safety Data

• Hazardous Substances Data: 222834-28-8(Hazardous Substances Data)

Upstream product

• 222834-30-2 (-)-2-ethoxy-3-(4-(2-phenoxazin-10-yl-ethoxy)-phenyl)-propionic acid 
• 222834-11-9 (+/-)-methyl 3-(4-(2-(10H-phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoate 
• 20989-17-7 (2S)-2-phenylglycinol 

Downstream Products

• 222834-30-2 ragaglitazar 

Relevant articles and documents

(-)3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid [(-)DRF 2725]: A dual PPAR agonist with potent antihyperglycemic and lipid modulating activity

(-)DRF 2725 (6) is a phenoxazine analogue of phenyl propanoic acid. Compound 6 showed interesting dual activation of PPARα and PPARγ. In insulin resistant db/db mice, 6 showed better reduction of plasma glucose and triglyceride levels as compared to rosig